Measuring eye changes to detect dementia
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
MD Stem Cells · NCT06613971
This study is testing a new eye exam to see if it can help tell the difference between people with and without dementia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | MD Stem Cells (industry) |
| Locations | 1 site (Coconut Creek, Florida) |
| Trial ID | NCT06613971 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the utility of dynamic light scattering spectroscopy, a noninvasive technique, in differentiating between patients with and without dementia by measuring changes in the eye. The research focuses on identifying which types of dementia can be detected and at what stages using this method. Participants will undergo an ophthalmic evaluation to ensure they can cooperate with the testing process. The study seeks to provide a new diagnostic tool for dementia, which is currently challenging to diagnose definitively until posthumously.
Who should consider this trial
Good fit: Ideal candidates include individuals capable of undergoing an ophthalmic evaluation and providing informed consent.
Not a fit: Patients who are not medically stable or at significant health risk may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of dementia, improving patient management and care.
How similar studies have performed: While the approach of using eye measurements for dementia detection is innovative, similar studies have shown promise in exploring noninvasive diagnostic techniques for neurological conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
1. All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation. 2. Patients must be capable of providing informed consent. 3. Patients who are not medically stable or who may be at significant risk to their health will not be eligible. 4. Women of child bearing age must not be pregnant at the time of examination.
Where this trial is running
Coconut Creek, Florida
- 3T Radiology — Coconut Creek, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Jeffrey N Weiss, MD — The Healing Institute
- Study coordinator: Jeffrey N Weiss, MD
- Email: jweissmd@me.com
- Phone: 954-608-7604
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dementia, Dementia Alzheimer Type, Spectroscopy, Dynamic Light Scattering Spectroscopy, Retinal Nerve Fiber Layer, DLS